Evaluation of S-600918 in Adults With Refractory Chronic Cough

  • STATUS
    Recruiting
  • End date
    May 25, 2021
  • participants needed
    372
  • sponsor
    Shionogi
Updated on 18 November 2020
unexplained chronic cough
refractory chronic cough

Summary

The primary objective of this study is to determine the optimal dose of S-600918 in patients with refractory chronic cough by evaluating the change from baseline in 24-hour cough frequency (coughs per hour) with S-600918 compared with placebo.

Details
Treatment S-600918, Placebo to S-600918
Clinical Study IdentifierNCT04110054
SponsorShionogi
Last Modified on18 November 2020

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study

user name

Annotated by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No made yet